CYP17 inhibition as a hormonal strategy for prostate cancer-Reference-Cited by-同舟云学术

CYP17 inhibition as a hormonal strategy for prostate cancer

Published:2008-11 Issue:11 Volume:5 Page:610-620
ISSN:1743-4270
Container-title:Nature Clinical Practice Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Reid Alison HM,Attard Gerhardt,Barrie Elaine,de Bono Johann S

Publisher

Springer Science and Business Media LLC

Subject

Urology,General Medicine

Link

http://www.nature.com/articles/ncpuro1237.pdf

Reference72 articles.

1. Huggins C and Hodges CV (1941) Studies on prostate cancer: the effect of castration, estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293–297

2. Hellerstedt BA and Pienta KJ (2002) The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52: 154–179

3. Taplin ME (2007) Drug Insight: role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Pract Oncol 4: 236–244

4. Small EJ and Ryan CJ (2006) The case for secondary hormonal therapies in the chemotherapy age. J Urol 176 (Suppl 1): S66–S71

5. Attard G et al. (2006) Improving the outcome of patients with castration-resistant prostate cancer through rational drug development. Br J Cancer 95: 767–774

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor β;Interdisciplinary Cancer Research;2023

2. Genitourinary Cancer: Updates on Treatments and Their Impact on the Kidney;Seminars in Nephrology;2022-11

3. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials;Signal Transduction and Targeted Therapy;2022-06-24

4. High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling;Cell Death Discovery;2022-03-22

5. The effects of selected inhibitors on human fetal adrenal steroidogenesis differs under basal and ACTH-stimulated conditions;BMC Medicine;2021-09-08